Novanta Q3 2026 net income drops 81% to USD 2.02 million

NOVT•2026-11-09

Novanta's third-quarter 2026 net income fell 81% year over year to USD 2.02 million, while revenue rose 23% to USD 305.01 million. The company forecast fourth-quarter revenue of USD 306 million to USD 312 million.

1. Quarterly results and outlook

Operating cash flow rose to USD 39.34 million. Novanta said it closed its largest acquisition, Riverpoint Medical, which is performing in line with management's expectations, and forecast fourth-quarter 2026 revenue of USD 306 million to USD 312 million.

Novanta Q3 2026 net income drops 81% to USD 2.02 million

1. Quarterly results and outlook

Related News

Everest Group director William F. Galtney Jr. reports $2.06 million common share sale

Concentra names Matthew DiCanio president and CEO

Microvast Q3 revenue drops 63% on weak vehicle demand; net loss widens

American Financial Group management to meet investors at Dowling & Partners forum

Sagard expects sticky inflation as markets price in easing pressures